# An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

Study · id `cardio:ct-nct04756180` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04756180](<https://clinicaltrials.gov/study/NCT04756180>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04756180

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.

## Technical summary

Registry record NCT04756180. Randomized; no masking; primary purpose treatment. Start 2016-10 (actual); primary completion 2019-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 248 participants (enrolled count; ClinicalTrials.gov record NCT04756180, source copy `cardio:ctgov-nct04756180-2021-03-05`, retrieved 2026-10-31)
- Started: 2016-10 (actual) (ClinicalTrials.gov record NCT04756180, source copy `cardio:ctgov-nct04756180-2021-03-05`, retrieved 2026-10-31)
- Primary completion: 2019-04 (actual) (ClinicalTrials.gov record NCT04756180, source copy `cardio:ctgov-nct04756180-2021-03-05`, retrieved 2026-10-31)
- Completion: 2019-04 (actual) (ClinicalTrials.gov record NCT04756180, source copy `cardio:ctgov-nct04756180-2021-03-05`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04756180-2021-03-05`, retrieved 2026-10-31)

## The registry's words

- Brief title: An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.
- Condition: Hypertriglyceridemia
- Intervention (Drug): Omega-3-acid ethyl ester or Placebo
- Lead sponsor: Abbott
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High triglycerides (`cardio:hypertriglyceridemia`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: a460c4d82f9c3e7d0bb82a4560f12c00e875b4991ee5d561d64b14cb685641ac
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
